Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2257 - 2264 of 11454 results
Cybersecurity and ERISA Fiduciary Responsibilities for Retirement Plans
October 5, 2021| News
Optis Puts Apple’s Feet to the UK Fire: Commit to FRAND or Be Snuffed Out
October 4, 2021| Blog| Viewpoint
California Legislature Passes New Key Privacy Laws, Expected to Be Signed Next Week
October 4, 2021| Blog| Viewpoint
Coverage of FDA’s AI/ML Medical Devices Workshop - Part 1: The History of FDA Software Regulation
October 4, 2021| Blog| Viewpoint
Breaking Down the New COVID-19 Safety Protocol Guidance for Federal Contractors and Subcontractors
October 1, 2021| Blog| Viewpoint
FTC Promises More Rigorous Merger Reviews
October 1, 2021| Alert| Viewpoint
PTAB “Overlooks” Rehearing Consequences and Swings the Rehearing Door Wide Open
October 1, 2021| Blog| Viewpoint
Drinks with the Deal: Mintz’s Matthew Simpson
October 1, 2021| News
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.